392 related articles for article (PubMed ID: 8589274)
1. The in vivo effect of recombinant human interleukin-1 receptor antagonist on spleen colony forming cells after radiation induced myelosuppression.
Milenkovíc P; Ivanovíc Z; Stosić-Grujicić S
Eur Cytokine Netw; 1995; 6(3):177-80. PubMed ID: 8589274
[TBL] [Abstract][Full Text] [Related]
2. In vivo effects of interleukin-1 receptor antagonist on hematopoietic bone marrow progenitor cells in normal mice.
Jovcic G; Ivanovic Z; Biljanovic-Paunovic L; Bugarski D; Stosic-Grujicic S; Milenkovic P
Eur Cytokine Netw; 1996; 7(1):71-4. PubMed ID: 8704098
[TBL] [Abstract][Full Text] [Related]
3. [The effect of specific interleukin-1 receptor blockade on hematopoietic stem cell proliferation].
Stosić-Grujicić S; Milenković P; Ivanović Z; Lukić M
Srp Arh Celok Lek; 1994; 122 Suppl 1():13-4. PubMed ID: 18173175
[TBL] [Abstract][Full Text] [Related]
4. [The effect of recombinant human interleukin-1 beta on the repopulation of bone-marrow colony-forming cells in mice subjected to the action of radiation and burns].
Alekseeva LV; Izotova NI; Ketlinskiĭ SA; Pereverzev AE; Simbirtsev AS
Tsitologiia; 1991; 33(3):88-94. PubMed ID: 1801379
[TBL] [Abstract][Full Text] [Related]
5. Copper(II)2(3,5-diisopropylsalicylate)4 stimulates hemopoiesis in normal and irradiated mice.
Soderberg LS; Barnett JB; Baker ML; Chang LW; Salari H; Sorenson JR
Exp Hematol; 1988 Aug; 16(7):577-80. PubMed ID: 3292276
[TBL] [Abstract][Full Text] [Related]
6. The effect of IL-1 receptor antagonist on the proliferation of hematopoietic progenitor cells in regenerating bone marrow.
Jovcić G; Ivanović Z; Biljanović-Paunović L; Bugarski D; Stosić-Grujicić S; Milenković P
Leukemia; 1996 Mar; 10(3):564-9. PubMed ID: 8642876
[TBL] [Abstract][Full Text] [Related]
7. Stem cell responses in myelosuppressed mice following sequential treatment with recombinant human interleukin 1 (rHuIL-1), recombinant murine interleukin 3 (rMuIL-3) and recombinant human macrophage colony-stimulating factor (rHuM-CSF).
Kovacs CJ; Harrell JP; Evans MJ; Abernathy RS; Roberts CJ; Johnke RM
Stem Cells; 1994 Jan; 12(1):103-13. PubMed ID: 8142915
[TBL] [Abstract][Full Text] [Related]
8. Radioprotection of mice with interleukin-1: relationship to the number of spleen colony-forming units.
Schwartz GN; Patchen ML; Neta R; MacVittie TJ
Radiat Res; 1989 Jul; 119(1):101-12. PubMed ID: 2787916
[TBL] [Abstract][Full Text] [Related]
9. Contrasting mechanisms of the myeloprotective effects of interleukin-1 against ionizing radiation and cytotoxic 5-fluorouracil.
Neta R; Keller JR; Ali N; Blanchette F; Dubois CM
Radiat Res; 1996 May; 145(5):624-31. PubMed ID: 8619029
[TBL] [Abstract][Full Text] [Related]
10. alpha-Galactosylceramide (AGL-517) treatment protects mice from lethal irradiation.
Inoue H; Koezuka Y; Nishi N; Osawa M; Motoki K; Kobayashi E; Kabaya K; Obuchi M; Fukushima H; Mori KJ
Exp Hematol; 1997 Aug; 25(9):935-44. PubMed ID: 9257806
[TBL] [Abstract][Full Text] [Related]
11. [Effect of beta-interleukin on the content and proliferation of hemopoietic precursor cells in intact and irradiated long-term cultures of the bone marrow].
Lebedev VG; Moroz BB; Deshevoĭ IuB
Patol Fiziol Eksp Ter; 2002; (4):2-4. PubMed ID: 12638418
[TBL] [Abstract][Full Text] [Related]
12. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
Drize N; Chertkov J; Samoilina N; Zander A
Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
[TBL] [Abstract][Full Text] [Related]
13. [Preiliminary studies on the efficacy and mechanism of interleukin-3 in the treatment of myelosuppression in mice].
Chen J; Hu W; Zhao S; Zhang Y
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 1997 May; 13(2):134-7. PubMed ID: 10074234
[TBL] [Abstract][Full Text] [Related]
14. Radioprotection of bone marrow stem cell subsets by interleukin-1 and kit-ligand: implications for CFU-S as the responsible target cell population.
van Os R; Lamont C; Witsell A; Mauch PM
Exp Hematol; 1997 Mar; 25(3):205-10. PubMed ID: 9091295
[TBL] [Abstract][Full Text] [Related]
15. Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression.
Tritarelli E; Greco G; Testa U; Belardelli F; Peschle C; Proietti E
Cancer Res; 1994 Dec; 54(24):6469-76. PubMed ID: 7987845
[TBL] [Abstract][Full Text] [Related]
16. Radioprotection of hemopoiesis conferred by Acanthopanax senticosus Harms (Shigoka) administered before or after irradiation.
Miyanomae T; Frindel E
Exp Hematol; 1988 Oct; 16(9):801-6. PubMed ID: 3049132
[TBL] [Abstract][Full Text] [Related]
17. Recovery of hematopoietic colony-forming cells in irradiated mice pretreated with interleukin 1 (IL-1).
Schwartz GN; Neta R; Vigneulle RM; Patchen ML; MacVittie TJ
Exp Hematol; 1988 Oct; 16(9):752-7. PubMed ID: 3262530
[TBL] [Abstract][Full Text] [Related]
18. Effects of juzen-taiho-toh (TJ-48), a traditional Oriental medicine, on hematopoietic recovery from radiation injury in mice.
Ohnishi Y; Yasumizu R; Fan HX; Liu J; Takao-Liu F; Komatsu Y; Hosoya E; Good RA; Ikehara S
Exp Hematol; 1990 Jan; 18(1):18-22. PubMed ID: 2298264
[TBL] [Abstract][Full Text] [Related]
19. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
[TBL] [Abstract][Full Text] [Related]
20. Temporal recovery of short-term repopulating HSC subpopulations in marrow following schedule-dependent administrations of IL-1 alpha and M-CSF.
Kovacs CJ; Evans MJ; Roberts C; Harrell J; Abernathy R; Gooya J; Johnke RM
Exp Hematol; 1995 Aug; 23(9):1016-23. PubMed ID: 7635181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
